Key result
Cloned influenza defective interfering RNA 1/244 protected mice from clinical disease and interfered with viral replication by replacing cognate full-length segment 1 RNA in progeny virions.
Why the study?
What is the RNA inhibitory mechanism of cloned influenza A DI RNA (1/244)?
What is the RNA inhibitory mechanism of cloned influenza A DI RNA (1/244)?
Answers are grounded in this paper and cite their sources.
Cloned influenza A DI RNA (1/244) exhibits unexpected complexity in its interference mechanism, inhibiting expression of multiple genome segments rather than just its cognate full-length segment.
BACKGROUND: Defective interfering (DI) viruses are natural antivirals made by nearly all viruses. They have a highly deleted genome (thus being non-infectious) and interfere with the replication of genetically related infectious viruses. We have produced the first potential therapeutic DI virus for the clinic by cloning an influenza A DI RNA (1/244) which was derived naturally from genome segment 1. This is highly effective in vivo, and has unexpectedly broad-spectrum activity with two different modes of action: inhibiting influenza A viruses through RNA interference, and all other (interferon-sensitive) respiratory viruses through stimulating interferon type I. RESULTS: We have investigated the RNA inhibitory mechanism(s) of DI 1/244 RNA. Ablation of initiation codons does not diminish interference showing that no protein product is required for protection. Further analysis indicated that 1/244 DI RNA interferes by replacing the cognate full-length segment 1 RNA in progeny virions, while interfering with the expression of genome segment 1, its cognate RNA, and genome RNAs 2 and 3, but not genome RNA 6, a representative of the non-polymerase genes. CONCLUSIONS: Our data contradict the dogma that a DI RNA only interferes with expression from its cognate full-length segment. There is reciprocity as cloned segment 2 and 3 DI RNAs inhibited expression of RNAs from a segment 1 target. These data demonstrate an unexpected complexity in the mechanism of interference by this cloned therapeutic DI RNA.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2017) studied Influenza A infection. Cloned influenza A defective interfering RNA (1/244 DI RNA) vs. A/WSN alone or A/WSN + inactivated DI virus was evaluated on Protection from clinical disease and interference with viral replication. Cloned influenza defective interfering RNA 1/244 protected mice from clinical disease and interfered with viral replication by replacing cognate full-length segment 1 RNA in progeny virions.
Synapse has enriched 10 related papers. Consider them for comparative context: